Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data at ASM Microbe 2016
20. Juni 2016 16:05 ET
|
Tetraphase Pharmaceuticals
WATERTOWN, Mass., June 20, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences Conference
15. Juni 2016 08:00 ET
|
Tetraphase Pharmaceuticals
WATERTOWN, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals Announces Presentation of Data at ASM Microbe 2016
23. Mai 2016 08:30 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., May 23, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced seventeen data presentations at the American Society of Microbiology (ASM) Microbe...
Tetraphase Pharmaceuticals Provides Update on Eravacycline Regulatory and Development Status
12. Mai 2016 16:05 ET
|
Tetraphase Pharmaceuticals, Inc.
– Additional phase 3 clinical trial in cIAI planned to support NDA filing – –Phase 3 clinical trial in cUTI planned for future supplemental NDA – – Company to host conference call at 4:30 p.m. ET...
Tetraphase Pharmaceuticals Reports First Quarter 2016 Financial Results
04. Mai 2016 16:30 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present Data at 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
07. April 2016 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced five data presentations at the 26th European Congress of Clinical Microbiology...
Tetraphase Pharmaceuticals to Present at Needham Conference 2016
06. April 2016 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 06, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals to Present at Roth Conference 2016
10. März 2016 09:10 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals Reports Fourth-Quarter and Full-Year 2015 Financial Results and Provides Corporate Update
23. Februar 2016 16:01 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals to Host Conference Call on February 23 to Discuss Fourth Quarter and Full Year Financial Results and Provide Corporate Update
19. Februar 2016 09:14 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...